Marilena Vrana: I Want to Thank Grifols Deutschland for The Opportunity to Visit Their Premises and Biotest AG Manufacturing Facility in Dreieich
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”I want to thank Grifols Deutschland for the opportunity to visit their premises and Biotest AG manufacturing facility in Dreieich, Germany last Friday.
Visiting the site alongside Anita Brikman and Marek Kortus was truly insightful.
I’m especially grateful to Petros Gatsios, Joerg Schuettrumpf, and Vera Ott, who guided us through the facility and shared their expertise.
With 400 skilled team members working around the clock, the site has the capacity to process nearly 3 million liters of plasma annually.
This was the first site I’ve visited where the entire process —from fractionation and purification to testing, production, and packaging —happens under one roof.
Plasma Protein Therapeutics Association (PPTA) member companies operate cutting-edge plants that transform plasma into life-saving therapies while also exemplifying the scale and importance of Europe’s plasma manufacturing capabilities.
Up next on my member agenda:
- Tomorrow PPTA Europe event with Euractiv on the EU Critical medicines act
- Next week: I’m looking forward to visiting Haema Blood Donation Service Centre in Berlin as part of International Plasma Awareness Week (IPAW2025) activities, alongside patients from the GBS|CIDP Foundation International.
Can’t wait to share more!”
Stay updated with Hemostasis Today.
-
Oct 6, 2025, 04:10EAHAD PT Committee Chair Ruth Elise Is Contributing to The Discussion On Joint Health and Mobility At EHC 2025
-
Oct 6, 2025, 03:44Caitlin Raymond: When We Talk About Plasma Exchange, Most Discussions Stop At What We’re Removing, But That’s Only Half The Story
-
Oct 6, 2025, 03:20Gianluigi Pasta On Cutting-Edge Cartilage Engineering for Bleeding Disorders Community at EHC 2025
-
Oct 5, 2025, 11:38Marc Vasse: Very Honored to Have Been Invited to Moderate the Session "Haemostasis and Oncology'' at 25th Moroccan Days of Clinical Biology
-
Oct 5, 2025, 08:32Maria Elisa Mancuso: During Day 2 of the Annual EHC Conference We Discussed Very Rare Bleeding Disorders!
-
Oct 6, 2025, 03:48New Insights On Pre-Existing AAV5 Abs in Haemophilia B Gene Therapy
-
Oct 6, 2025, 03:40Emmanuel J Favaloro and Leonardo Pasalic's Commentary On Acquired von Willebrand Syndrome in Children
-
Oct 5, 2025, 12:43Nita Radhakrishnan and Colleagues on Tertiary Prophylaxis with Extended Half-life Factor in LMIC Settings
-
Oct 5, 2025, 12:15Laura Avila and Colleagues on Childhood DVT: Upper Extremity (UE) Post-thrombotic Syndrome (PTS)
-
Oct 5, 2025, 11:54Laura Girardi on Anticoagulant Treatment for Isolated Distal DVT: Finally Our Official Paper Is Out!
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 2, 2025, 04:572025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
-
Oct 1, 2025, 15:59Anirban Sen Gupta: Thrilled to share a great collaboration story in Nature Portfolio
-
Oct 6, 2025, 03:57Mattia Galli - Nominated Among The Top 200 of 200,000 Leading Researchers Worldwide for The 2025 USERN Prize!
-
Oct 6, 2025, 03:46Marilena Vrana: I Want to Thank Grifols Deutschland for The Opportunity to Visit Their Premises and Biotest AG Manufacturing Facility in Dreieich
-
Oct 6, 2025, 03:43Maha Othman: Real-World Learning Is Essential in Preparing Our Future Nurses!
-
Oct 6, 2025, 03:10Moath Albliwi to Present 4 Major Posters at 67th ASH Annual Meeting 2025
-
Oct 5, 2025, 12:29Miguel Crato: I Feel I Must Always Be Strong, But That Wears Me Down